Transamerica Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$879K Buy
4,734
+12
+0.3% +$2.23K 0.08% 169
2025
Q1
$990K Sell
4,722
-885
-16% -$186K 0.1% 156
2024
Q4
$997K Buy
5,607
+610
+12% +$108K 0.1% 148
2024
Q3
$987K Sell
4,997
-2,232
-31% -$441K 0.1% 156
2024
Q2
$1.24M Hold
7,229
0.13% 116
2024
Q1
$1.32M Sell
7,229
-4,026
-36% -$733K 0.13% 126
2023
Q4
$1.75M Sell
11,255
-983
-8% -$152K 0.24% 69
2023
Q3
$1.83M Sell
12,238
-1,079
-8% -$161K 0.25% 67
2023
Q2
$1.8M Buy
13,317
+1,079
+9% +$145K 0.23% 72
2023
Q1
$1.95M Sell
12,238
-782
-6% -$125K 0.26% 65
2022
Q4
$2.11M Sell
13,020
-1,570
-11% -$254K 0.3% 59
2022
Q3
$1.96M Buy
14,590
+1,629
+13% +$219K 0.29% 61
2022
Q2
$1.99M Buy
+12,961
New +$1.99M 0.28% 56
2021
Q3
Sell
-3
Closed -$1K 117
2021
Q2
$1K Sell
3
-12
-80% -$4K 0.02% 78
2021
Q1
$2K Hold
15
0.05% 62
2020
Q4
$2K Buy
15
+8
+114% +$1.07K 0.04% 63
2020
Q3
$1K Sell
7
-15,826
-100% -$2.26M 0.02% 134
2020
Q2
$1.56M Buy
+15,833
New +$1.56M 0.34% 56
2019
Q3
Sell
-2,548
Closed -$186K 97
2019
Q2
$186K Buy
+2,548
New +$186K 0.04% 171
2019
Q1
Sell
-2,653
Closed -$245K 100
2018
Q4
$245K Sell
2,653
-133
-5% -$12.3K 0.06% 146
2018
Q3
$264K Buy
2,786
+355
+15% +$33.6K 0.06% 164
2018
Q2
$226K Sell
2,431
-3,618
-60% -$336K 0.05% 179
2018
Q1
$573K Buy
+6,049
New +$573K 0.08% 166
2017
Q1
Sell
-55
Closed -$4K 393
2016
Q4
$4K Buy
+55
New +$4K ﹤0.01% 261
2016
Q2
Sell
-854
Closed -$49K 391
2016
Q1
$49K Sell
854
-5,579
-87% -$320K ﹤0.01% 371
2015
Q4
$382K Hold
6,433
0.03% 263
2015
Q3
$350K Sell
6,433
-228
-3% -$12.4K 0.03% 247
2015
Q2
$448K Buy
6,661
+5,360
+412% +$360K 0.03% 235
2015
Q1
$77K Sell
1,301
-101
-7% -$5.98K 0.01% 390
2014
Q4
$92K Buy
1,402
+4
+0.3% +$262 0.01% 324
2014
Q3
$81K Buy
1,398
+182
+15% +$10.5K 0.01% 311
2014
Q2
$69K Sell
1,216
-9,444
-89% -$536K 0.01% 347
2014
Q1
$548K Buy
10,660
+10,227
+2,362% +$526K 0.05% 144
2013
Q4
$23K Hold
433
﹤0.01% 399
2013
Q3
$20K Hold
433
﹤0.01% 385
2013
Q2
$18K Buy
+433
New +$18K ﹤0.01% 367